Speratum Competitors and Similar CompaniesClear all

Speratum's competitors and similar companies include Gossamer Bio, Foghorn Therapeutics and Neovii.

	Speratum Speratum is a biotechnology company developing targeted molecular therapies for the treatment of cancer.	Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.	Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.	Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
Founding Date	Founding Date 2014	Founding Date 2015	Founding Date 2016	Founding Date 2003
Type	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy
Locations	Locations HQ	Locations San Diego, US HQ Dublin 2, IE	Locations Cambridge, US HQ Cambridge, US	Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US
Employees	Employees 9	Employees 11820% increase	Employees 1123% decrease	Employees 1193% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 208 m	Valuation ($) 452 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $48.5m (FY, 2025)	Revenue (est.) $30.9m (FY, 2025)	Revenue (est.) N/A
Net income	Net income N/A	Net income ($170.4m) (FY, 2025)	Net income ($74.4m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 2.8m	Total funding raised $ 480m	Total funding raised $ 50m	Total funding raised N/A

For sources of this data, please see the company profile

View Company Profiles

Gossamer Bio

San Diego, US

Employees

118↑ 20% increase

Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.

View company

Foghorn Therapeutics

Cambridge, US

Employees

112↓ 3% decrease

Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.

View company

Neovii

Rapperswil-Jona, CH

Employees

119↑ 3% increase

Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.